News on clinical chemistry systems and applications.
The partners plan to validate the accuracy, effectiveness, and clinical implications of Group K's MultiNostic liver function test, which is pending FDA clearance.
The merger is aimed at expanding Salveo’s diagnostics capabilities and improving communication with providers and patients.
Representatives of NBs said they are adding capacity to allow oversight of the anticipated wave of submissions before the new IVD Regulation comes into force in three years.
The combined company will offer laboratory testing and digital technologies for diagnosing and managing lupus, multiple sclerosis, and other autoimmune diseases.
A study by clinicians at St. Louis's Barnes-Jewish Hospital found that staff overrode alerts designed to warn of unnecessary lab testing roughly half the time.
